Aurinia Pharmaceuticals Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $80.2M | $83.4M | $48.8M | $94.1M | $231.6M | $272.4M | $306.0M | $118.0M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | $45.7M | $39.2M | $39.7M | $24.8M | $19.3M | $13.9M | $0 | — |
| Total Current Assets | $492.0M | $446.6M | $424.8M | $442.5M | $513.3M | $419.4M | $315.1M | $132.8M |
| Property, Plant & Equipment | $2.1M | $2.7M | $3.4M | $3.7M | $4.4M | $4.8M | $93.0K | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $3.8M | $4.4M | $5.0M | $6.4M | $8.4M | $9.3M | $8.9M | — |
| Total Assets | $751.6M | $550.6M | $548.1M | $470.9M | $543.4M | $463.7M | $324.3M | $145.9M |
| Liabilities | ||||||||
| Accounts Payable | $3.3M | $5.2M | $4.3M | $3.1M | $3.9M | $2.6M | $4.2M | $7.1M |
| Total Current Liabilities | $93.7M | $97.8M | $77.2M | $46.1M | $40.6M | $32.0M | $11.3M | $7.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $170.3M | $173.2M | $170.1M | $65.4M | $64.3M | $55.9M | $25.7M | $10.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-649.4M | $-936.6M | $-942.3M | $-864.3M | $-756.1M | $-575.2M | $-472.5M | $-416.0M |
| Total Stockholders' Equity | $581.3M | $377.5M | $378.0M | $405.4M | $479.1M | $407.8M | $298.6M | $135.7M |